Rein Therapeutics
RNTX
#9959
Rank
HK$0.53 B
Marketcap
HK$6.27
Share price
-4.75%
Change (1 day)
-48.44%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2026 (TTM): -HK$0.17 Billion

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$0.18 Billion, an increase over its 2024 earnings that were of -HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.17 Billion-2.03%
2025 -HK$0.18 Billion-21.99%
2024 -HK$0.23 Billion83.16%
2023 -HK$0.13 Billion-44.49%
2022 -HK$0.22 Billion3.92%
2021 -HK$0.21 Billion29.81%
2020 -HK$0.17 Billion-31.58%
2019 -HK$0.24 Billion-6.1%
2018 -HK$0.26 Billion38.66%
2017 -HK$0.19 Billion26.63%
2016 -HK$0.15 Billion